228 related articles for article (PubMed ID: 20299679)
1. Multiplex enzyme assay for galactosemia using ultraperformance liquid chromatography-tandem mass spectrometry.
Ko DH; Jun SH; Park HD; Song SH; Park KU; Kim JQ; Song YH; Song J
Clin Chem; 2010 May; 56(5):764-71. PubMed ID: 20299679
[TBL] [Abstract][Full Text] [Related]
2. Newborn screening for galactosemia by a second-tier multiplex enzyme assay using UPLC-MS/MS in dried blood spots.
Ko DH; Jun SH; Park KU; Song SH; Kim JQ; Song J
J Inherit Metab Dis; 2011 Apr; 34(2):409-14. PubMed ID: 21340634
[TBL] [Abstract][Full Text] [Related]
3. Quantification of galactose-1-phosphate uridyltransferase enzyme activity by liquid chromatography-tandem mass spectrometry.
Li Y; Ptolemy AS; Harmonay L; Kellogg M; Berry GT
Clin Chem; 2010 May; 56(5):772-80. PubMed ID: 20348403
[TBL] [Abstract][Full Text] [Related]
4. An interference-free two-step enzyme assay with UPLC-tandem mass spectrometric product measurement for the clinical diagnosis of uridine diphosphate galactose-4-epimerase deficiency.
Chen J; Meyers GA; Bennett MJ
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 May; 959():5-9. PubMed ID: 24732214
[TBL] [Abstract][Full Text] [Related]
5. Multiplex tandem mass spectrometry assay for newborn screening of X-linked adrenoleukodystrophy, biotinidase deficiency, and galactosemia with flexibility to assay other enzyme assays and biomarkers.
Hong X; Kumar AB; Ronald Scott C; Gelb MH
Mol Genet Metab; 2018 Jun; 124(2):101-108. PubMed ID: 29680633
[TBL] [Abstract][Full Text] [Related]
6. The ability of an LC-MS/MS-based erythrocyte GALT enzyme assay to predict the phenotype in subjects with GALT deficiency.
Demirbas D; Huang X; Daesety V; Feenstra S; Haskovic M; Qi W; Gubbels CS; Hecht L; Levy HL; Waisbren SE; Berry GT
Mol Genet Metab; 2019 Apr; 126(4):368-376. PubMed ID: 30718057
[TBL] [Abstract][Full Text] [Related]
7. Ultra fast and sensitive liquid chromatography tandem mass spectrometry based assay for galactose-1-phosphate uridylyltransferase and galactokinase deficiencies.
Li Y; Ptolemy AS; Harmonay L; Kellogg M; Berry GT
Mol Genet Metab; 2011 Jan; 102(1):33-40. PubMed ID: 20863731
[TBL] [Abstract][Full Text] [Related]
8. Liquid chromatography-tandem mass spectrometry enzyme assay for UDP-galactose 4'-epimerase: use of fragment intensity ratio in differentiation of structural isomers.
Li Y; Huang X; Harmonay L; Liu Y; Kellogg MD; Fridovich-Keil JL; Berry GT
Clin Chem; 2014 May; 60(5):783-90. PubMed ID: 24578239
[TBL] [Abstract][Full Text] [Related]
9. Direct non-radioactive assay of galactose-1-phosphate:uridyltransferase activity using high performance liquid chromatography.
Lindhout M; Rubio-Gozalbo ME; Bakker JA; Bierau J
Clin Chim Acta; 2010 Jul; 411(13-14):980-3. PubMed ID: 20359473
[TBL] [Abstract][Full Text] [Related]
10. Ultra-performance liquid chromatography-tandem mass spectrometry-based multiplex enzyme assay for six enzymes associated with hereditary hemolytic anemia.
Park CM; Lee K; Jun SH; Song SH; Song J
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Aug; 1060():76-83. PubMed ID: 28600963
[TBL] [Abstract][Full Text] [Related]
11. Structure and function of enzymes of the Leloir pathway for galactose metabolism.
Holden HM; Rayment I; Thoden JB
J Biol Chem; 2003 Nov; 278(45):43885-8. PubMed ID: 12923184
[No Abstract] [Full Text] [Related]
12. Hereditary galactosemia.
Demirbas D; Coelho AI; Rubio-Gozalbo ME; Berry GT
Metabolism; 2018 Jun; 83():188-196. PubMed ID: 29409891
[TBL] [Abstract][Full Text] [Related]
13. Epimerase-deficiency galactosemia is not a binary condition.
Openo KK; Schulz JM; Vargas CA; Orton CS; Epstein MP; Schnur RE; Scaglia F; Berry GT; Gottesman GS; Ficicioglu C; Slonim AE; Schroer RJ; Yu C; Rangel VE; Keenan J; Lamance K; Fridovich-Keil JL
Am J Hum Genet; 2006 Jan; 78(1):89-102. PubMed ID: 16385452
[TBL] [Abstract][Full Text] [Related]
14. Problems in the diagnosis of transferase and galactokinase deficient galactosemia.
Pesce MA; Bodourian SH
Ann Clin Lab Sci; 1980; 10(1):26-32. PubMed ID: 7362195
[TBL] [Abstract][Full Text] [Related]
15. The molecular basis of galactosemia - Past, present and future.
Timson DJ
Gene; 2016 Sep; 589(2):133-41. PubMed ID: 26143117
[TBL] [Abstract][Full Text] [Related]
16. Galactose and cataract.
Stambolian D
Surv Ophthalmol; 1988; 32(5):333-49. PubMed ID: 3043741
[TBL] [Abstract][Full Text] [Related]
17. Rare cases of galactose metabolic disorders: identification of more than two mutations per patient.
Schulpis KH; Thodi G; Chatzidaki M; Iakovou K; Molou E; Dotsikas Y; Loukas YL
J Pediatr Endocrinol Metab; 2017 Oct; 30(10):1119-1120. PubMed ID: 28902631
[No Abstract] [Full Text] [Related]
18. Diagnosis of inherited disorders of galactose metabolism.
Cuthbert C; Klapper H; Elsas L
Curr Protoc Hum Genet; 2008 Jan; Chapter 17():Unit 17.5. PubMed ID: 18428423
[TBL] [Abstract][Full Text] [Related]
19. Drosophila melanogaster Models of Galactosemia.
Daenzer JM; Fridovich-Keil JL
Curr Top Dev Biol; 2017; 121():377-395. PubMed ID: 28057307
[TBL] [Abstract][Full Text] [Related]
20. The occurrence of the Leloir pathway in non-pathogenic mycobacteria.
Szumiło T
Acta Microbiol Pol; 1981; 30(4):327-33. PubMed ID: 6179392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
